Incyte
INCY · NASDAQ · Pharmaceuticals, Biotech · Founded 1991
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.
Current Price
$116.80
Market Cap
$23.7B
Return Since Last Split
+33%
Last Split
Sep 1, 2000
Total Splits
2
Cumulative Multiple
4×
What If You Bought INCY Earlier?
Investment
Purchase Date (Before Split)
Worth Today
$46,720
400 shares · 4×
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth from that date to today.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Sep 1, 2000 | $41.47 | 2-for-1 | 2× | 4× |
| Nov 10, 1997 | — | 2-for-1 | 2× | 2× |
Incyte Market Cap Timeline
Validated annual market-cap history is available from 1996. Split markers cover all 2 recorded splits. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.
Frequently Asked Questions
Incyte's latest record in the split calendar is a 2-for-1 forward split effective 2000-09-01.